Global Phakic Intraocular Lens (PIOL) Market Growth 2025-2031
The global Phakic Intraocular Lens (PIOL) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.
Phakic Intraocular Lens is made of a highly purified biosilica gel with good biocompatibility. Under a microscope, an intraocular lens with a degree is implanted in the posterior chamber of the patient's eye (behind the iris and in front of the natural lens) to achieve the purpose of correcting myopia. This surgery replaces spectacles or hospital spectacles and improves the uncorrected vision of patients. It has the same leading position as the new generation of excimer laser surgery in correcting vision with refractive surgery, so that patients with high myopia can get safe and effective vision correction.
Key Features- Market growth predictions for 2025 to 2031.
- Analysis of Phakic Intraocular Lens usage in various regions.
- Overview of market players and their shares.
- Anterior Chamber Type
- Posterior Type
- Iris Clip Type
- Hospital
- Clinic
- Americas
- APAC
- Europe
- Middle East & Africa
- CIBA Vision
- STAAR Surgical
- Ophtec B.V.
- Johnson Johnson
- Care Group
- Zeiss
- Alcon
- Shanghai Haohai Biological Technology
- Eyebright Medical Technology
- What is the 10-year outlook for the global Phakic Intraocular Lens (PIOL) market?
- What factors are driving Phakic Intraocular Lens (PIOL) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Phakic Intraocular Lens (PIOL) market opportunities vary by end market size?
- How does Phakic Intraocular Lens (PIOL) break out by Type, by Application?
Frequently Asked Questions
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market